Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07574567
Familia Imara: A Parenting Program to Reduce Family Violence in TanzaniaEmory UniversityRecruitingNot Applicable
NCT07574567Recruiting
Not Applicable
Familia Imara: A Parenting Program to Reduce Family Violence in TanzaniaEmory University
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07576894
Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary DiseaseNational Heart, Lung, and Blood Institute (NHLBI)RecruitingNot Applicable
NCT07576894Recruiting
Not Applicable
Right Ventricular Response to Exercise Among Patients With Chronic Obstructive P...National Heart, Lung, and...
NCT07575503
Diagnostic Value of Photon-Counting CT in Subsegmental Pulmonary EmbolismSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityRecruiting
NCT07575503Recruiting
—
Diagnostic Value of Photon-Counting CT in Subsegmental Pulmonary EmbolismSecond Affiliated Hospita...
NCT07574528
A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell LymphomaSun Yat-sen UniversityNot Yet RecruitingPhase 2
NCT07574528Not Yet Recruiting
Phase 2
A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiother...Sun Yat-sen University
NCT07574658
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample: a Study Protocol of a Randomized Clinical TrialUniversity of Sao PauloNot Yet RecruitingPhase 3
NCT07574658Not Yet Recruiting
Phase 3
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample:...University of Sao Paulo
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterNot Yet RecruitingPhase 2
NCT07576725Not Yet Recruiting
Phase 2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metas...Fred Hutchinson Cancer Ce...
NCT07576881
Impact of Standardization on Outcomes Following Cervical RipeningIndiana UniversityNot Yet RecruitingPhase 2
NCT07576881Not Yet Recruiting
Phase 2
Impact of Standardization on Outcomes Following Cervical RipeningIndiana University
NCT07576140
Effects of Mobilization With Movement and Active Release Technique in Patients With Lateral EpicondylitisRiphah International UniversityCompletedNot Applicable
NCT07576140Completed
Not Applicable
Effects of Mobilization With Movement and Active Release Technique in Patients W...Riphah International Univ...
NCT07575828
Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial FibrillationMedtronic Cardiac Ablation SolutionsNot Yet RecruitingNot Applicable
NCT07575828Not Yet Recruiting
Not Applicable
Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) S...Medtronic Cardiac Ablatio...
NCT07575932
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)PfizerNot Yet RecruitingPhase 2
NCT07575932Not Yet Recruiting
Phase 2
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOL...Pfizer
NCT07576309
Repetitive GON Blockade for Menstrual MigraineSaglik Bilimleri UniversitesiCompletedNot Applicable
NCT07576309Completed
Not Applicable
Repetitive GON Blockade for Menstrual MigraineSaglik Bilimleri Universi...
NCT07575880
Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care PathwayCentre Hospitalier de la côte BasqueNot Yet Recruiting
NCT07575880Not Yet Recruiting
—
Screening for Obstructive Respiratory Disorders in the General Population During...Centre Hospitalier de la...
NCT07575373
Evaluating the Feasibility of an Interdisciplinary Primary Care-based Intervention to Improve Transitions to Follow-Up Care for Hospitalized Patients With Substance Use DisordersMichael InczeNot Yet RecruitingNot Applicable
NCT07575373Not Yet Recruiting
Not Applicable
Evaluating the Feasibility of an Interdisciplinary Primary Care-based Interventi...Michael Incze
NCT07575659
Early Intervention in Cerebral Palsy: Perception-Action vs Neurodevelopmental TherapyTuba Derya DoğanNot Yet RecruitingNot Applicable
NCT07575659Not Yet Recruiting
Not Applicable
Early Intervention in Cerebral Palsy: Perception-Action vs Neurodevelopmental Th...Tuba Derya Doğan
NCT07575945
A Study to Learn if a Medicine Called Itraconazole Changes How the Body Processes the Study Medicine PF-08642534 in Healthy Adults.PfizerNot Yet RecruitingPhase 1
NCT07575945Not Yet Recruiting
Phase 1
A Study to Learn if a Medicine Called Itraconazole Changes How the Body Processe...Pfizer
NCT07576439
Influence of Keratinized Tissue Width and Attached Gingiva Width on Root Coverage in Patients With Recession Defects: A Prospective Clinical StudyPostgraduate Institute of Dental Sciences RohtakNot Yet RecruitingNot Applicable
NCT07576439Not Yet Recruiting
Not Applicable
Influence of Keratinized Tissue Width and Attached Gingiva Width on Root Coverag...Postgraduate Institute of...
NCT07575191
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic CancerSmartwise Sweden ABNot Yet RecruitingPhase 1
NCT07575191Not Yet Recruiting
Phase 1
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral...Smartwise Sweden AB
NCT07575243
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut UniversityCompleted
NCT07575243Completed
—
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut University
Result Breakdown
Not yet recruiting13 (65%)
Recruiting4 (20%)
Completed3 (15%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 24 (20%)
Phase 12 (10%)
Phase 31 (5%)